HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹28 Cr | ₹24 Cr | ₹80 Cr | ₹78 Cr | ₹73 Cr |
What is the latest Long Term Provisions ratio of HIKAL ?
| Year | Long Term Provisions |
|---|---|
| Mar2024 | ₹28 Cr |
| Mar2023 | ₹24 Cr |
| Mar2022 | ₹80 Cr |
| Mar2021 | ₹78 Cr |
| Mar2020 | ₹73 Cr |
How is Long Term Provisions of HIKAL Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2024 | ₹28 Cr | 15.55 | |
| Mar2023 | ₹24 Cr | -69.56 | |
| Mar2022 | ₹80 Cr | 2.11 | |
| Mar2021 | ₹78 Cr | 6.15 | |
| Mar2020 | ₹73 Cr | - | |
Compare Long Term Provisions of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹3,247.1 Cr | -1.8% | -23.3% | -19.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹390,192.0 Cr | 0.3% | -4% | -6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,479.0 Cr | 2% | -9.6% | 33.1% | Stock Analytics | |
| CIPLA | ₹125,113.0 Cr | 1.9% | 4.5% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹123,539.0 Cr | 0.6% | 3.6% | 9.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,926.0 Cr | 2% | -1% | -7% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -1.8% |
-23.3% |
-19.5% |
| SENSEX | 1.3% |
-0.8% |
3.2% |
You may also like the below Video Courses